Online-Ressource | |
Verfasst von: | Abdallah Khalafallah, Alhossain [VerfasserIn] |
Egerer, Gerlinde [VerfasserIn] | |
Weber-Nordt, Renate [VerfasserIn] | |
Körbling, M. [VerfasserIn] | |
Haas, R. [VerfasserIn] | |
Ho, Anthony Dick [VerfasserIn] | |
Titel: | Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution |
Titelzusatz: | adverse events and incidence of secondary myelodysplasia |
Verf.angabe: | A. Abdallah, G. Egerer, R.M. Weber-Nordt, M. Körbling, R. Haas and A.D. Ho |
E-Jahr: | 2002 |
Jahr: | 2002 Jul 16 |
Umfang: | 8 S. |
Illustrationen: | Diagramme |
Fussnoten: | Gesehen am 14.12.2021 |
Titel Quelle: | Enthalten in: Bone marrow transplantation |
Ort Quelle: | London : Springer Nature, 1997 |
Jahr Quelle: | 2002 |
Band/Heft Quelle: | 30(2002), 1, Seite 15-22 |
ISSN Quelle: | 1476-5365 |
Abstract: | We have analyzed the long-term outcome and toxicities in 98 patients with high-risk acute myelogenous leukemia (AML) who were treated with autologous bone marrow transplantation (ABMT) and monitored for a median observation period of 11.67 years. Between 1983 and 1994, 98 patients in our institution in first or second and higher complete remission (CR) underwent total body irradiation and high-dose cyclophosphamide prior to ABMT purged with mafosfamide. Twenty-seven out of the 90 evaluable patients (30%) were alive and in continuous CR for a median of 11.67 years (range, 6.39-15.53) after ABMT and could be considered as ‘cured’. Among the 90 patients, 39 were transplanted at first CR and had a significantly higher survival rate than those transplanted at ⩾2 CR. Younger patients (<40 years) had a better prognosis and patients with FAB M1-4 had a more favorable outcome than those with M5. Long-term complications included four patients with cardiac complications, two with renal insufficiency. Five developed HCV infections, four myelodysplastic syndrome. The incidence of cataract among the long-term survivors was 44.4%. Therefore, a significant number of adult patients with AML in first CR derived long-term benefit from ABMT, despite the risks of a few long-term complications and of MDS (4.4%). |
DOI: | doi:10.1038/sj.bmt.1703586 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt. Volltext ; Verlag: https://doi.org/10.1038/sj.bmt.1703586 |
Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092354/ | |
DOI: https://doi.org/10.1038/sj.bmt.1703586 | |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1782122591 |
Verknüpfungen: | → Zeitschrift |